Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.82+0.02 (+0.53%)
Close on Nov 13, 2026Market cap $549.66MP/E 26.0Yield –
Anbio Biotechnology EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was $0.15, up 162.5% from the year before.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.15 | +162.5% |
| FY2024 | Dec 31, 2024 | $0.06 | -46.7% |
| FY2023 | Dec 31, 2023 | $0.10 | -100.0% |
| FY2022 | Dec 31, 2022 | $100112.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?